Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juergen Behr

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 4, 2013
Mortality, a bar too high for idiopathic pulmonary fibrosis clinical trials!Juergen Behr
Respirology (Carlton, Vic.)|May 27, 2015
Changes in the current classification of IIP: A critical reviewClaus Neurohr, Juergen Behr
Expert Opinion on Pharmacotherapy|September 28, 2014
Riociguat for the treatment of pulmonary hypertensionTobias Meis, Juergen Behr
Current Vascular Pharmacology|December 15, 2010
Pulmonary hypertension: role of combination therapyTobias Meis, Juergen Behr
American Journal of Respiratory and Critical Care Medicine|March 7, 2009
Update in diffuse parenchymal lung disease 2008Juergen Behr, Victor J Thannickal
Thorax|December 18, 2013
Determining collateral ventilation during bronchoscopy: unanswered questionsWolfgang Gesierich, Konstantinos Samitas, Juergen Behr
The European Respiratory Journal|April 15, 2016
Collapse phenomenon during Chartis collateral ventilation assessmentWolfgang Gesierich, Konstantinos Samitas, Frank Reichenberger, et al.
American Journal of Respiratory and Critical Care Medicine|February 3, 2018
Taking Another View on Lung FibrosisEdith Silbernagel, David Bondesson, Juergen Behr, et al.
The European Respiratory Journal|May 18, 2013
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trialGanesh Raghu, Rachel Million-Rousseau, Adele Morganti, et al.
International Journal of Occupational and Environmental Health|August 28, 2007
High prevalence of pneumonia in children of a smelter townYvonne Kohlhammer, Peter Rzehak, Juergen Behr, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|June 4, 2013
Mortality, a bar too high for idiopathic pulmonary fibrosis clinical trials!Juergen Behr
Respirology (Carlton, Vic.)|May 27, 2015
Changes in the current classification of IIP: A critical reviewClaus Neurohr, Juergen Behr
Expert Opinion on Pharmacotherapy|September 28, 2014
Riociguat for the treatment of pulmonary hypertensionTobias Meis, Juergen Behr
Current Vascular Pharmacology|December 15, 2010
Pulmonary hypertension: role of combination therapyTobias Meis, Juergen Behr
American Journal of Respiratory and Critical Care Medicine|March 7, 2009
Update in diffuse parenchymal lung disease 2008Juergen Behr, Victor J Thannickal
Thorax|December 18, 2013
Determining collateral ventilation during bronchoscopy: unanswered questionsWolfgang Gesierich, Konstantinos Samitas, Juergen Behr
The European Respiratory Journal|April 15, 2016
Collapse phenomenon during Chartis collateral ventilation assessmentWolfgang Gesierich, Konstantinos Samitas, Frank Reichenberger, et al.
American Journal of Respiratory and Critical Care Medicine|February 3, 2018
Taking Another View on Lung FibrosisEdith Silbernagel, David Bondesson, Juergen Behr, et al.
The European Respiratory Journal|May 18, 2013
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trialGanesh Raghu, Rachel Million-Rousseau, Adele Morganti, et al.
International Journal of Occupational and Environmental Health|August 28, 2007
High prevalence of pneumonia in children of a smelter townYvonne Kohlhammer, Peter Rzehak, Juergen Behr, et al.
Pageof 10